VNOO Vornado latest quarterly earnings release omits core performance metrics leaving investors awaiting further operational updates SEIC SEI tops Q1 2026 EPS consensus forecasts yet shares fall 243 in negative investor response PLYX Polaryx Therapeutics highlights rare disease pipeline progress in its newly released quarterly earnings report Regeneron Pharmaceuticals REGN NearTerm Margin Pressures Mount Following White House MFN Pricing Agreement and Free Otarmeni Access Pledge